Ausgabe 1/2011
Inhalt (12 Artikel)
Adjuvant chemotherapy in stage IB NSCLC: implication of the new TNM staging system
- Short review
M. Dediu
Maintenance therapy for patients with advanced non-small cell lung cancer: Who to treat and how to treat?
- Review
S. I. Rothschild, O. Gautschi
Targeted therapies in advanced non-small cell lung cancer: success or failure?
- Short Review
E. Szutowicz, K. Konopa, J. Jassem
Mitomycin C in combination with vinorelbine or cisplatin and erythropoietin in pretreated patients with in field relapse after radiation therapy of non-small cell lung cancer: a phase II trial of the AIO
- Original report
I. Stenger, C. Tomala, M. Pietsch, U. Olgemoeller, W. Koerber, B. Fischer, M. Sebastian, L. Truemper, T. Overbeck, F. Griesinger
STAT signalling in malignant mesothelioma: Is there a regulatory effect of microRNAs?
- Original report
L. Arzt, H. Kothmaier, F. Quehenberger, I. Halbwedl, H. H. Popper
Comorbidity – an important domain in elderly cancer patients' assessment
- Short review
R. Simanek, J. Walczuk, K. Geissler
Associations of serum uric acid and gamma-glutamyltransferase with cancer in the Vorarlberg Health Monitoring and Promotion Programme (VHM&PP) – a short review
- Short review
M. Edlinger, G. Nagel, W. Hilbe, G. Diem, H. Concin, Alexander M. Strasak, H. Ulmer
